[S02DA03, antipyrine, The metabolism of Erdafitinib can be decreased when combined with Antipyrine.]
[J01EC02, sulfadiazine, The metabolism of Erdafitinib can be decreased when combined with Sulfadiazine.]
[S01AB01, sulfamethizole, The metabolism of Erdafitinib can be decreased when combined with Sulfamethizole.]
[J01EC01, sulfamethoxazole, The metabolism of Erdafitinib can be decreased when combined with Sulfamethoxazole.]
[J01EC03, sulfamoxole, The metabolism of Erdafitinib can be decreased when combined with Sulfamoxole.]
[J01EB04, sulfapyridine, The metabolism of Erdafitinib can be decreased when combined with Sulfapyridine.]
[M04AB02, sulfinpyrazone, The metabolism of Erdafitinib can be increased when combined with Sulfinpyrazone.]
[S01AB02, sulfisoxazole, The metabolism of Erdafitinib can be decreased when combined with Sulfisoxazole.]
[A10BB04, glibornuride, The metabolism of Erdafitinib can be decreased when combined with Glibornuride.]
[L02BA01, tamoxifen, The metabolism of Erdafitinib can be increased when combined with Tamoxifen.]
[L01CB02, teniposide, The metabolism of Erdafitinib can be decreased when combined with Teniposide.]
[B01AE07, dabigatran etexilate, The serum concentration of Dabigatran etexilate can be increased when it is combined with Erdafitinib.]
[G03BA03, testosterone, The metabolism of Erdafitinib can be increased when combined with Testosterone.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Tetracaine.]
[S03AA02, tetracycline, The metabolism of Erdafitinib can be decreased when combined with Tetracycline.]
[A04AD10, dronabinol, The metabolism of Erdafitinib can be decreased when combined with Dronabinol.]
[L04AX02, thalidomide, The metabolism of Erdafitinib can be decreased when combined with Thalidomide.]
[V04CJ01, thyrotropin, The therapeutic efficacy of Thyrotropin can be decreased when used in combination with Erdafitinib.]
[V04CJ02, thyrotropin-releasing hormone, The therapeutic efficacy of Protirelin can be decreased when used in combination with Erdafitinib.]
[B01AC05, ticlopidine, The metabolism of Erdafitinib can be decreased when combined with Ticlopidine.]
[A10BB05, tolazamide, The metabolism of Erdafitinib can be decreased when combined with Tolazamide.]
[V04CA01, tolbutamide, The metabolism of Erdafitinib can be decreased when combined with Tolbutamide.]
[N06AF04, tranylcypromine, The metabolism of Erdafitinib can be decreased when combined with Tranylcypromine.]
[L01XF01, tretinoin, The metabolism of Erdafitinib can be decreased when combined with Tretinoin.]
[S01BA05, triamcinolone, The metabolism of Erdafitinib can be increased when combined with Triamcinolone.]
[R03BA07, mometasone, The metabolism of Erdafitinib can be increased when combined with Mometasone.]
[N03AC02, trimethadione, The metabolism of Erdafitinib can be decreased when combined with Trimethadione.]
[J01EA01, trimethoprim, The metabolism of Erdafitinib can be decreased when combined with Trimethoprim.]
[N06AA06, trimipramine, The serum concentration of Trimipramine can be increased when it is combined with Erdafitinib.]
[J01FA08, troleandomycin, The metabolism of Erdafitinib can be decreased when combined with Troleandomycin.]
[R03DX07, roflumilast, The metabolism of Erdafitinib can be decreased when combined with Roflumilast.]
[A10BH05, linagliptin, The serum concentration of Linagliptin can be increased when it is combined with Erdafitinib.]
[J05AP03, boceprevir, The metabolism of Erdafitinib can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Erdafitinib can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Erdafitinib can be decreased when combined with Rilpivirine.]
[B01AF01, rivaroxaban, The serum concentration of Rivaroxaban can be increased when it is combined with Erdafitinib.]
[R03AC18, indacaterol, The serum concentration of Indacaterol can be increased when it is combined with Erdafitinib.]
[B01AC24, ticagrelor, The serum concentration of Ticagrelor can be increased when it is combined with Erdafitinib.]
[C08DA01, verapamil, The metabolism of Erdafitinib can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Erdafitinib can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The serum concentration of Vinblastine can be increased when it is combined with Erdafitinib.]
[L01CA02, vincristine, The serum concentration of Vincristine can be increased when it is combined with Erdafitinib.]
[A11HA03, vitamin E, The metabolism of Erdafitinib can be increased when combined with Vitamin E.]
[B01AA03, warfarin, The metabolism of Erdafitinib can be increased when combined with Warfarin.]
[J05AF01, zidovudine, The metabolism of Erdafitinib can be decreased when combined with Zidovudine.]
[N05AF05, zuclopenthixol, The metabolism of Erdafitinib can be decreased when combined with Zuclopenthixol.]
[J05AE02, indinavir, The metabolism of Erdafitinib can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The serum concentration of Vemurafenib can be increased when it is combined with Erdafitinib.]
[L01FX05, brentuximab vedotin, The serum concentration of Brentuximab vedotin can be increased when it is combined with Erdafitinib.]
[L01ED01, crizotinib, The metabolism of Erdafitinib can be decreased when combined with Crizotinib.]
[R03DC01, zafirlukast, The metabolism of Erdafitinib can be decreased when combined with Zafirlukast.]
[H05BX03, doxercalciferol, The risk or severity of adverse effects can be increased when Doxercalciferol is combined with Erdafitinib.]
[N05AE04, ziprasidone, The metabolism of Erdafitinib can be decreased when combined with Ziprasidone.]
[G03AC10, drospirenone, The metabolism of Erdafitinib can be decreased when combined with Drospirenone.]
[N02BA01, aspirin, The metabolism of Erdafitinib can be decreased when combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, The metabolism of Erdafitinib can be decreased when combined with Ruxolitinib.]
[G04BD07, tolterodine, The metabolism of Erdafitinib can be decreased when combined with Tolterodine.]
[A11CC03, alfacalcidol, The risk or severity of adverse effects can be increased when Alfacalcidol is combined with Erdafitinib.]
[J02AC03, voriconazole, The metabolism of Erdafitinib can be decreased when combined with Voriconazole.]
[L01XJ01, vismodegib, The metabolism of Erdafitinib can be decreased when combined with Vismodegib.]
[L01EK01, axitinib, The serum concentration of Axitinib can be increased when it is combined with Erdafitinib.]
[R07AX02, ivacaftor, The metabolism of Erdafitinib can be decreased when combined with Ivacaftor.]
[H02AB11, prednylidene, The metabolism of Erdafitinib can be increased when combined with Prednylidene.]
[B03XA04, peginesatide, The risk or severity of Thrombosis can be increased when Peginesatide is combined with Erdafitinib.]
[L01BC05, gemcitabine, The serum concentration of Gemcitabine can be increased when it is combined with Erdafitinib.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Erdafitinib.]
[G04BD12, mirabegron, The serum concentration of Mirabegron can be increased when it is combined with Erdafitinib.]
[L01XG02, carfilzomib, The serum concentration of Carfilzomib can be increased when it is combined with Erdafitinib.]
[V03AX03, cobicistat, The metabolism of Erdafitinib can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Erdafitinib can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The metabolism of Erdafitinib can be increased when combined with Enzalutamide.]
[L01EA04, bosutinib, The serum concentration of Bosutinib can be increased when it is combined with Erdafitinib.]
[A02AA05, magnesium silicate, The risk or severity of adverse effects can be increased when Magnesium silicate is combined with Erdafitinib.]
[A02AC02, calcium silicate, The risk or severity of adverse effects can be increased when Calcium silicate is combined with Erdafitinib.]
[L01EX05, regorafenib, The serum concentration of Regorafenib can be increased when it is combined with Erdafitinib.]
[N05CA04, barbital, The metabolism of Erdafitinib can be increased when combined with Barbital.]
[J05AE04, nelfinavir, The metabolism of Erdafitinib can be decreased when combined with Nelfinavir.]
[L01AA09, bendamustine, The serum concentration of Bendamustine can be increased when it is combined with Erdafitinib.]
[N06DA02, donepezil, The metabolism of Erdafitinib can be decreased when combined with Donepezil.]
[N03AX22, perampanel, The metabolism of Erdafitinib can be increased when combined with Perampanel.]
[L01EX07, cabozantinib, The metabolism of Erdafitinib can be decreased when combined with Cabozantinib.]
[H01CB05, pasireotide, The metabolism of Erdafitinib can be decreased when combined with Pasireotide.]
[G04BE03, sildenafil, The serum concentration of Sildenafil can be increased when it is combined with Erdafitinib.]
[B01AF02, apixaban, The serum concentration of Apixaban can be increased when it is combined with Erdafitinib.]
[C10AX12, lomitapide, The metabolism of Erdafitinib can be decreased when combined with Lomitapide.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Erdafitinib can be increased when combined with Glycerol phenylbutyrate.]
[L04AX06, pomalidomide, The serum concentration of Pomalidomide can be increased when it is combined with Erdafitinib.]
[G03XC05, ospemifene, The metabolism of Erdafitinib can be decreased when combined with Ospemifene.]
[A10BK02, canagliflozin, The serum concentration of Canagliflozin can be increased when it is combined with Erdafitinib.]
[M04AB03, benzbromarone, The metabolism of Erdafitinib can be decreased when combined with Benzbromarone.]
[A06AX06, tegaserod, The serum concentration of Tegaserod can be increased when it is combined with Erdafitinib.]
[H03AA04, tiratricol, The therapeutic efficacy of Tiratricol can be decreased when used in combination with Erdafitinib.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Benzocaine.]
[M01AH01, celecoxib, The metabolism of Erdafitinib can be decreased when combined with Celecoxib.]
[L04AA18, everolimus, The serum concentration of Everolimus can be increased when it is combined with Erdafitinib.]
[L01EC02, dabrafenib, The metabolism of Erdafitinib can be increased when combined with Dabrafenib.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Benzyl alcohol.]
[H05AA03, parathyroid hormone, The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Erdafitinib.]
[L01EB03, afatinib, The serum concentration of Afatinib can be increased when it is combined with Erdafitinib.]
[J05AJ03, dolutegravir, The serum concentration of Dolutegravir can be increased when it is combined with Erdafitinib.]
[C02KX05, riociguat, The serum concentration of Riociguat can be increased when it is combined with Erdafitinib.]
[N06AX26, vortioxetine, The metabolism of Erdafitinib can be decreased when combined with Vortioxetine.]
[N03AF04, eslicarbazepine, The metabolism of Erdafitinib can be increased when combined with Eslicarbazepine.]
[J05AP05, simeprevir, The serum concentration of Simeprevir can be increased when it is combined with Erdafitinib.]
[J05AP08, sofosbuvir, The serum concentration of Sofosbuvir can be increased when it is combined with Erdafitinib.]
[A10BK01, dapagliflozin, The metabolism of Erdafitinib can be decreased when combined with Dapagliflozin.]
[N05CH03, tasimelteon, The metabolism of Erdafitinib can be decreased when combined with Tasimelteon.]
[A16AA07, metreleptin, The metabolism of Erdafitinib can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Erdafitinib can be increased when combined with Apremilast.]
[L02BG02, formestane, The metabolism of Erdafitinib can be increased when combined with Formestane.]
[S03BA03, betamethasone, The metabolism of Erdafitinib can be increased when combined with Betamethasone.]
[L04AC11, siltuximab, The metabolism of Erdafitinib can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The serum concentration of Ceritinib can be increased when it is combined with Erdafitinib.]
[B01AC26, vorapaxar, The metabolism of Erdafitinib can be decreased when combined with Vorapaxar.]
[B01AA07, acenocoumarol, The metabolism of Erdafitinib can be decreased when combined with Acenocoumarol.]
[L01XH04, belinostat, The serum concentration of Belinostat can be increased when it is combined with Erdafitinib.]
[L01EM01, idelalisib, The serum concentration of Idelalisib can be increased when it is combined with Erdafitinib.]
[R03AC19, olodaterol, The metabolism of Erdafitinib can be decreased when combined with Olodaterol.]
[N05CM19, suvorexant, The metabolism of Erdafitinib can be decreased when combined with Suvorexant.]
[J01XA05, oritavancin, The metabolism of Erdafitinib can be increased when combined with Oritavancin.]
[A06AH03, naloxegol, The serum concentration of Naloxegol can be increased when it is combined with Erdafitinib.]
[L04AX05, pirfenidone, The metabolism of Erdafitinib can be decreased when combined with Pirfenidone.]
[L01EX09, nintedanib, The serum concentration of Nintedanib can be increased when it is combined with Erdafitinib.]
[S03AA06, gentamicin, The serum concentration of Gentamicin can be increased when it is combined with Erdafitinib.]
[J05AP09, dasabuvir, The serum concentration of Dasabuvir can be increased when it is combined with Erdafitinib.]
[L01XK01, olaparib, The metabolism of Erdafitinib can be decreased when combined with Olaparib.]
[B01AA01, dicumarol, The metabolism of Erdafitinib can be decreased when combined with Dicoumarol.]
[B01AF03, edoxaban, The serum concentration of Edoxaban can be increased when it is combined with Erdafitinib.]
[N06AX11, mirtazapine, The metabolism of Erdafitinib can be decreased when combined with Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Erdafitinib can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Erdafitinib can be decreased when combined with Palbociclib.]
[L01EX08, lenvatinib, The serum concentration of Lenvatinib can be increased when it is combined with Erdafitinib.]
[L01XH03, panobinostat, The serum concentration of Panobinostat can be increased when it is combined with Erdafitinib.]
[N02BE01, acetaminophen, The metabolism of Erdafitinib can be increased when combined with Acetaminophen.]
[J05AP06, asunaprevir, The metabolism of Erdafitinib can be increased when combined with Asunaprevir.]
[A06AD03, magnesium peroxide, The risk or severity of adverse effects can be increased when Magnesium peroxide is combined with Erdafitinib.]
[S01EC01, acetazolamide, The metabolism of Erdafitinib can be decreased when combined with Acetazolamide.]
[A02BC03, lansoprazole, The metabolism of Erdafitinib can be decreased when combined with Lansoprazole.]
[L01CX01, trabectedin, The metabolism of Erdafitinib can be decreased when combined with Trabectedin.]
[J02AC05, isavuconazole, The metabolism of Erdafitinib can be increased when combined with Isavuconazole.]
[L01EB04, osimertinib, The serum concentration of Osimertinib can be increased when it is combined with Erdafitinib.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Erdafitinib.]
[L01EE02, cobimetinib, The serum concentration of Cobimetinib can be increased when it is combined with Erdafitinib.]
[B01AC27, selexipag, The serum concentration of Selexipag can be increased when it is combined with Erdafitinib.]
[A10BB31, acetohexamide, The metabolism of Erdafitinib can be decreased when combined with Acetohexamide.]
[M04AB05, lesinurad, The metabolism of Erdafitinib can be increased when combined with Lesinurad.]
[J05AP10, elbasvir, The serum concentration of Elbasvir can be increased when it is combined with Erdafitinib.]
[J05AP11, grazoprevir, The serum concentration of Grazoprevir can be increased when it is combined with Erdafitinib.]
[N05CA05, aprobarbital, The metabolism of Erdafitinib can be increased when combined with Aprobarbital.]
[A02AB06, aloglutamol, The risk or severity of adverse effects can be increased when Aloglutamol is combined with Erdafitinib.]
[N03AX23, brivaracetam, The metabolism of Erdafitinib can be decreased when combined with Brivaracetam.]
[L01XX52, venetoclax, The serum concentration of Venetoclax can be increased when it is combined with Erdafitinib.]
[A02AD05, aluminum magnesium silicate, The risk or severity of adverse effects can be increased when Almasilate is combined with Erdafitinib.]
[A02AB03, aluminum phosphate, The risk or severity of adverse effects can be increased when Aluminium phosphate is combined with Erdafitinib.]
[N05AX17, pimavanserin, The metabolism of Erdafitinib can be decreased when combined with Pimavanserin.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Bupivacaine.]
[N07BC01, buprenorphine, The metabolism of Erdafitinib can be decreased when combined with Buprenorphine.]
[P01BE02, artemether, The metabolism of Erdafitinib can be decreased when combined with Artemether.]
[S01GX07, azelastine, The metabolism of Erdafitinib can be decreased when combined with Azelastine.]
[L01XK03, rucaparib, The metabolism of Erdafitinib can be decreased when combined with Rucaparib.]
[S01AA26, azithromycin, The metabolism of Erdafitinib can be decreased when combined with Azithromycin.]
[L01EF02, ribociclib, The metabolism of Erdafitinib can be decreased when combined with Ribociclib.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Oxybuprocaine.]
[H05BX05, calcifediol, The risk or severity of adverse effects can be increased when Calcifediol is combined with Erdafitinib.]
[D05AX03, calcitriol, The risk or severity of adverse effects can be increased when Calcitriol is combined with Erdafitinib.]
[A12AA04, calcium carbonate, The risk or severity of adverse effects can be increased when Calcium carbonate is combined with Erdafitinib.]
[J05AE09, tipranavir, The metabolism of Erdafitinib can be decreased when combined with Tipranavir.]
[H03BA03, benzylthiouracil, The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Erdafitinib.]
[L04AB02, infliximab, The metabolism of Erdafitinib can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Erdafitinib can be decreased when combined with Midostaurin.]
[H05AA04, abaloparatide, The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Erdafitinib.]
[L04AC14, sarilumab, The metabolism of Erdafitinib can be increased when combined with Sarilumab.]
[J01MA23, delafloxacin, The metabolism of Erdafitinib can be increased when combined with Delafloxacin.]
[B01AF04, betrixaban, The serum concentration of Betrixaban can be increased when it is combined with Erdafitinib.]
[D01AC10, bifonazole, The metabolism of Erdafitinib can be decreased when combined with Bifonazole.]
[L01BC06, capecitabine, The metabolism of Erdafitinib can be decreased when combined with Capecitabine.]
[L01XX59, enasidenib, The metabolism of Erdafitinib can be increased when combined with Enasidenib.]
[L01FB01, inotuzumab ozogamicin, The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Erdafitinib.]
[L01EM02, copanlisib, The serum concentration of Copanlisib can be increased when it is combined with Erdafitinib.]
[L01EF03, abemaciclib, The serum concentration of Abemaciclib can be increased when it is combined with Erdafitinib.]
[A02BX12, bismuth subnitrate, The risk or severity of adverse effects can be increased when Bismuth subnitrate is combined with Erdafitinib.]
[C07AB07, bisoprolol, The serum concentration of Bisoprolol can be increased when it is combined with Erdafitinib.]
[J05AG03, efavirenz, The metabolism of Erdafitinib can be decreased when combined with Efavirenz.]
[R03BA02, budesonide, The metabolism of Erdafitinib can be increased when combined with Budesonide.]
[L01EL02, acalabrutinib, The metabolism of Erdafitinib can be decreased when combined with Acalabrutinib.]
[J05AX18, letermovir, The metabolism of Erdafitinib can be decreased when combined with Letermovir.]
[C01AA02, acetyldigoxins, Erdafitinib may decrease the excretion rate of Acetyldigoxin which could result in a higher serum level.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Capsaicin.]
[A10BK04, ertugliflozin, The serum concentration of Ertugliflozin can be increased when it is combined with Erdafitinib.]
[L02BB05, apalutamide, The metabolism of Erdafitinib can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Erdafitinib can be increased when combined with Carbamazepine.]
[H03BB01, carbimazole, The therapeutic efficacy of Carbimazole can be decreased when used in combination with Erdafitinib.]
[C07AG02, carvedilol, The metabolism of Erdafitinib can be decreased when combined with Carvedilol.]
[B02BX09, fostamatinib, The metabolism of Erdafitinib can be decreased when combined with Fostamatinib.]
[N03AX24, cannabidiol, The metabolism of Erdafitinib can be decreased when combined with Cannabidiol.]
[B02BX08, avatrombopag, The serum concentration of Avatrombopag can be increased when it is combined with Erdafitinib.]
[L01EE03, binimetinib, The serum concentration of Binimetinib can be increased when it is combined with Erdafitinib.]
[H01CC03, elagolix, The serum concentration of Elagolix can be increased when it is combined with Erdafitinib.]
[L01XX62, ivosidenib, The metabolism of Erdafitinib can be increased when combined with Ivosidenib.]
[N03AX17, stiripentol, The metabolism of Erdafitinib can be decreased when combined with Stiripentol.]
[B02BX07, lusutrombopag, The serum concentration of Lusutrombopag can be increased when it is combined with Erdafitinib.]
[J05AX24, tecovirimat, The metabolism of Erdafitinib can be increased when combined with Tecovirimat.]
[L01EM04, duvelisib, The serum concentration of Duvelisib can be increased when it is combined with Erdafitinib.]
[L01EB07, dacomitinib, The serum concentration of Dacomitinib can be increased when it is combined with Erdafitinib.]
[J01AA15, omadacycline, The serum concentration of Omadacycline can be increased when it is combined with Erdafitinib.]
[A10BB06, carbutamide, The metabolism of Carbutamide can be decreased when combined with Erdafitinib.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Chloroprocaine.]
[M01AC05, lornoxicam, The metabolism of Erdafitinib can be decreased when combined with Lornoxicam.]
[L01XK04, talazoparib, The serum concentration of Talazoparib can be increased when it is combined with Erdafitinib.]
[R03BB08, revefenacin, The serum concentration of Revefenacin can be increased when it is combined with Erdafitinib.]
[L01ED05, lorlatinib, The metabolism of Erdafitinib can be increased when combined with Lorlatinib.]
[L04AA39, emapalumab, The metabolism of Erdafitinib can be increased when combined with Emapalumab.]
[L01EX12, larotrectinib, The serum concentration of Larotrectinib can be increased when it is combined with Erdafitinib.]
[L01EX13, gilteritinib, The serum concentration of Gilteritinib can be increased when it is combined with Erdafitinib.]
[L01XJ03, glasdegib, The serum concentration of Glasdegib can be increased when it is combined with Erdafitinib.]
[A06AX05, prucalopride, The serum concentration of Prucalopride can be increased when it is combined with Erdafitinib.]
[P02BX04, triclabendazole, The metabolism of Erdafitinib can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The metabolism of Erdafitinib can be increased when combined with Esketamine.]
[L04AA42, siponimod, The metabolism of Erdafitinib can be decreased when combined with Siponimod.]
[J01FA09, clarithromycin, The metabolism of Erdafitinib can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, The serum concentration of Solriamfetol can be increased when it is combined with Erdafitinib.]
[S01AA13, fusidic acid, The metabolism of Erdafitinib can be decreased when combined with Fusidic acid.]
[N05BA09, clobazam, The serum concentration of Clobazam can be increased when it is combined with Erdafitinib.]
[H02AB14, cloprednol, The metabolism of Erdafitinib can be increased when combined with Cloprednol.]
[C09CA06, candesartan, The metabolism of Erdafitinib can be decreased when combined with Candesartan.]
[L04AB01, etanercept, The metabolism of Erdafitinib can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The metabolism of Erdafitinib can be increased when combined with Cortivazol.]
[L01EM03, alpelisib, The metabolism of Erdafitinib can be increased when combined with Alpelisib.]
[L02BB06, darolutamide, The serum concentration of Darolutamide can be increased when it is combined with Erdafitinib.]
[L01EJ02, fedratinib, The serum concentration of Fedratinib can be increased when it is combined with Erdafitinib.]
[N07XX11, pitolisant, The serum concentration of Erdafitinib can be decreased when it is combined with Pitolisant.]
[J04AK08, pretomanid, The metabolism of Erdafitinib can be decreased when combined with Pretomanid.]
[J01XX12, lefamulin, The serum concentration of Lefamulin can be increased when it is combined with Erdafitinib.]
[N04CX01, istradefylline, The metabolism of Erdafitinib can be decreased when combined with Istradefylline.]
[J01XX09, daptomycin, The serum concentration of Daptomycin can be increased when it is combined with Erdafitinib.]
[J01DB01, cephalexin, The metabolism of Erdafitinib can be decreased when combined with Cephalexin.]
[J01DB09, cephradine, The metabolism of Erdafitinib can be increased when combined with Cefradine.]
[H02AB13, deflazacort, The metabolism of Erdafitinib can be increased when combined with Deflazacort.]
[N02CC08, lasmiditan, The serum concentration of Lasmiditan can be increased when it is combined with Erdafitinib.]
[G03AC09, desogestrel, The metabolism of Erdafitinib can be decreased when combined with Desogestrel.]
[B06AX03, voxelotor, The serum concentration of Erdafitinib can be increased when it is combined with Voxelotor.]
[N03AX25, cenobamate, The serum concentration of Erdafitinib can be decreased when it is combined with Cenobamate.]
[N02CD04, ubrogepant, The serum concentration of Ubrogepant can be increased when it is combined with Erdafitinib.]
[L01FX13, enfortumab vedotin, The serum concentration of Enfortumab vedotin can be increased when it is combined with Erdafitinib.]
[S01XA12, dexpanthenol, The risk or severity of adverse effects can be increased when Dexpanthenol is combined with Erdafitinib.]
[L01EX18, avapritinib, The metabolism of Erdafitinib can be decreased when combined with Avapritinib.]
[N05CM21, lemborexant, The serum concentration of Lemborexant can be increased when it is combined with Erdafitinib.]
[L01XX72, tazemetostat, The serum concentration of Tazemetostat can be increased when it is combined with Erdafitinib.]
[M01AX21, diacetylrhein, The metabolism of Erdafitinib can be decreased when combined with Diacerein.]
[N02CD06, rimegepant, The serum concentration of Rimegepant can be increased when it is combined with Erdafitinib.]
[J05AB16, remdesivir, The metabolism of Erdafitinib can be decreased when combined with Remdesivir.]
[H02CA02, osilodrostat, The metabolism of Erdafitinib can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Erdafitinib can be decreased when combined with Amprenavir.]
[L01EE04, selumetinib, The serum concentration of Selumetinib can be increased when it is combined with Erdafitinib.]
[N02CC06, eletriptan, The metabolism of Erdafitinib can be decreased when combined with Eletriptan.]
[M01AH02, rofecoxib, The metabolism of Erdafitinib can be increased when combined with Rofecoxib.]
[L01XF03, bexarotene, The metabolism of Erdafitinib can be increased when combined with Bexarotene.]
[C08CA16, clevidipine, The metabolism of Erdafitinib can be increased when combined with Clevidipine.]
[C01BD07, dronedarone, The serum concentration of Erdafitinib can be increased when it is combined with Dronedarone.]
[J01FA13, dirithromycin, The metabolism of Erdafitinib can be decreased when combined with Dirithromycin.]
[S03AA08, chloramphenicol, The metabolism of Erdafitinib can be decreased when combined with Chloramphenicol.]
[L01EH03, tucatinib, The serum concentration of Tucatinib can be increased when it is combined with Erdafitinib.]
[D07XB03, fluprednidene, The metabolism of Erdafitinib can be increased when combined with Fluprednidene.]
[L01EX19, ripretinib, The serum concentration of Ripretinib can be increased when it is combined with Erdafitinib.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Dyclonine.]
[R06AX22, ebastine, The metabolism of Erdafitinib can be decreased when combined with Ebastine.]
[J05AX29, fostemsavir, The serum concentration of Fostemsavir can be increased when it is combined with Erdafitinib.]
[P01BB01, proguanil, The metabolism of Erdafitinib can be decreased when combined with Proguanil.]
[L01FX15, belantamab mafodotin, The serum concentration of Belantamab mafodotin can be increased when it is combined with Erdafitinib.]
[L04AC19, satralizumab, The serum concentration of Erdafitinib can be decreased when it is combined with Satralizumab.]
[L01EX23, pralsetinib, The serum concentration of Pralsetinib can be increased when it is combined with Erdafitinib.]
[N05AA01, chlorpromazine, The metabolism of Erdafitinib can be increased when combined with Chlorpromazine.]
[A10BB02, chlorpropamide, The metabolism of Erdafitinib can be decreased when combined with Chlorpropamide.]
[A11CC05, cholecalciferol, The risk or severity of adverse effects can be increased when Cholecalciferol is combined with Erdafitinib.]
[M01AB08, etodolac, The metabolism of Erdafitinib can be decreased when combined with Etodolac.]
[B06AC06, berotralstat, The serum concentration of Berotralstat can be increased when it is combined with Erdafitinib.]
[A16AX20, lonafarnib, The metabolism of Erdafitinib can be decreased when combined with Lonafarnib.]
[L02BX04, relugolix, The serum concentration of Relugolix can be increased when it is combined with Erdafitinib.]
[L04AD03, voclosporin, The serum concentration of Voclosporin can be increased when it is combined with Erdafitinib.]
[P03AX07, abametapir, The serum concentration of Erdafitinib can be increased when it is combined with Abametapir.]
[L01EX21, tepotinib, The serum concentration of Tepotinib can be increased when it is combined with Erdafitinib.]
[V03AF12, trilaciclib, The serum concentration of Trilaciclib can be increased when it is combined with Erdafitinib.]
[N03AX10, felbamate, The metabolism of Erdafitinib can be increased when combined with Felbamate.]
[R03BA03, flunisolide, The metabolism of Erdafitinib can be increased when combined with Flunisolide.]
[S02BA08, fluocinolone acetonide, The metabolism of Erdafitinib can be increased when combined with Fluocinolone acetonide.]
[R03CC15, formoterol, The metabolism of Erdafitinib can be decreased when combined with Formoterol.]
[L01EK03, tivozanib, The serum concentration of Tivozanib can be increased when it is combined with Erdafitinib.]
[L03AB10, peginterferon alfa-2b, The metabolism of Erdafitinib can be increased when combined with Peginterferon alfa-2b.]
[G03GA06, follitropin beta, The therapeutic efficacy of Follitropin can be decreased when used in combination with Erdafitinib.]
[L01FX22, loncastuximab tesirine, The serum concentration of Loncastuximab tesirine can be increased when it is combined with Erdafitinib.]
[A02BA01, cimetidine, The metabolism of Erdafitinib can be decreased when combined with Cimetidine.]
[N07CA02, cinnarizine, The metabolism of Erdafitinib can be decreased when combined with Cinnarizine.]
[L01XX73, sotorasib, The serum concentration of Erdafitinib can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The metabolism of Erdafitinib can be decreased when combined with Infigratinib.]
[S03AA07, ciprofloxacin, The metabolism of Erdafitinib can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, The serum concentration of Cisplatin can be increased when it is combined with Erdafitinib.]
[N06AB04, citalopram, The metabolism of Erdafitinib can be decreased when combined with Citalopram.]
[P01CA03, fexinidazole, The metabolism of Erdafitinib can be decreased when combined with Fexinidazole.]
[L01XX74, belzutifan, The serum concentration of Erdafitinib can be decreased when it is combined with Belzutifan.]
[L01EB10, mobocertinib, The serum concentration of Erdafitinib can be decreased when it is combined with Mobocertinib.]
[L04AA59, avacopan, The metabolism of Erdafitinib can be decreased when combined with Avacopan.]
[M01AG01, mefenamic acid, The metabolism of Erdafitinib can be decreased when combined with Mefenamic acid.]
[A10BB12, glimepiride, The metabolism of Erdafitinib can be decreased when combined with Glimepiride.]
[A10BB08, gliquidone, The metabolism of Erdafitinib can be decreased when combined with Gliquidone.]
[N06AX25, St. John's wort extract, The metabolism of Erdafitinib can be increased when combined with St. John's Wort.]
[L01EA06, asciminib, The serum concentration of Erdafitinib can be increased when it is combined with Asciminib.]
[D11AH08, abrocitinib, The metabolism of Abrocitinib can be decreased when combined with Erdafitinib.]
[J04BA01, clofazimine, The metabolism of Erdafitinib can be decreased when combined with Clofazimine.]
[C10AB01, clofibrate, The metabolism of Erdafitinib can be increased when combined with Clofibrate.]
[B06AX04, mitapivat, The metabolism of Erdafitinib can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The serum concentration of Erdafitinib can be increased when it is combined with Pacritinib.]
[G03GB02, clomiphene, The serum concentration of Clomifene can be increased when it is combined with Erdafitinib.]
[C01EB24, mavacamten, The serum concentration of Erdafitinib can be decreased when it is combined with Mavacamten.]
[A04AA01, ondansetron, The metabolism of Erdafitinib can be decreased when combined with Ondansetron.]
[J05AX31, lenacapavir, The metabolism of Erdafitinib can be decreased when combined with Lenacapavir.]
[N05AH02, clozapine, The metabolism of Erdafitinib can be increased when combined with Clozapine.]
[L01EN04, futibatinib, The serum concentration of Futibatinib can be increased when it is combined with Erdafitinib.]
[H01AC08, somatrogon, The metabolism of Erdafitinib can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Cocaine.]
[L04AC21, bimekizumab, The metabolism of Erdafitinib can be increased when combined with Bimekizumab.]
[M04AC01, colchicine, The serum concentration of Colchicine can be increased when it is combined with Erdafitinib.]
[L04AA13, leflunomide, The metabolism of Erdafitinib can be decreased when combined with Leflunomide.]
[A02AD04, hydrotalcite, The risk or severity of adverse effects can be increased when Hydrotalcite is combined with Erdafitinib.]
[A10BX03, nateglinide, The metabolism of Erdafitinib can be decreased when combined with Nateglinide.]
[J01FA15, telithromycin, The metabolism of Erdafitinib can be decreased when combined with Telithromycin.]
[M01AH03, valdecoxib, The metabolism of Erdafitinib can be decreased when combined with Valdecoxib.]
[M01AH04, parecoxib, The metabolism of Erdafitinib can be decreased when combined with Parecoxib.]
[J02AC02, itraconazole, The metabolism of Erdafitinib can be decreased when combined with Itraconazole.]
[N05BA10, ketazolam, The metabolism of Erdafitinib can be decreased when combined with Ketazolam.]
[L01EA01, imatinib, The serum concentration of Erdafitinib can be increased when it is combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Erdafitinib can be decreased when combined with Posaconazole.]
[B03XA02, darbepoetin alfa, The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Erdafitinib.]
[S01BA03, cortisone, The metabolism of Erdafitinib can be increased when combined with Cortisone.]
[A02AD02, magaldrate, The risk or severity of adverse effects can be increased when Magaldrate is combined with Erdafitinib.]
[A06AD01, magnesium carbonate, The risk or severity of adverse effects can be increased when Magnesium carbonate is combined with Erdafitinib.]
[C08CA11, manidipine, The metabolism of Erdafitinib can be decreased when combined with Manidipine.]
[H02AB15, meprednisone, The metabolism of Erdafitinib can be increased when combined with Meprednisone.]
[R06AD07, mequitazine, The metabolism of Erdafitinib can be decreased when combined with Mequitazine.]
[R06AE03, cyclizine, The metabolism of Erdafitinib can be decreased when combined with Cyclizine.]
[J01FA03, midecamycin, The metabolism of Erdafitinib can be decreased when combined with Midecamycin.]
[J05AF07, tenofovir disoproxil, The serum concentration of Tenofovir disoproxil can be increased when it is combined with Erdafitinib.]
[L01AA01, cyclophosphamide, The metabolism of Erdafitinib can be increased when combined with Cyclophosphamide.]
[S01XA18, cyclosporine, The serum concentration of Cyclosporine can be increased when it is combined with Erdafitinib.]
[N06BA07, modafinil, The metabolism of Erdafitinib can be increased when combined with Modafinil.]
[C10AA07, rosuvastatin, The metabolism of Erdafitinib can be decreased when combined with Rosuvastatin.]
[C03XA02, conivaptan, The metabolism of Erdafitinib can be decreased when combined with Conivaptan.]
[G04BE09, vardenafil, The serum concentration of Vardenafil can be increased when it is combined with Erdafitinib.]
[M01AH05, etoricoxib, The metabolism of Erdafitinib can be decreased when combined with Etoricoxib.]
[L01DA01, dactinomycin, The serum concentration of Dactinomycin can be increased when it is combined with Erdafitinib.]
[G03XA01, danazol, The metabolism of Erdafitinib can be decreased when combined with Danazol.]
[J04BA02, dapsone, The metabolism of Erdafitinib can be increased when combined with Dapsone.]
[L01DB02, daunorubicin, The metabolism of Erdafitinib can be decreased when combined with Daunorubicin.]
[A04AD11, nabilone, The metabolism of Erdafitinib can be decreased when combined with Nabilone.]
[M01AX01, nabumetone, The metabolism of Erdafitinib can be decreased when combined with Nabumetone.]
[N06AX06, nefazodone, The metabolism of Erdafitinib can be decreased when combined with Nefazodone.]
[L02BB02, nilutamide, The metabolism of Erdafitinib can be decreased when combined with Nilutamide.]
[N06AA01, desipramine, The metabolism of Erdafitinib can be decreased when combined with Desipramine.]
[L01XA03, oxaliplatin, The serum concentration of Oxaliplatin can be increased when it is combined with Erdafitinib.]
[N03AF02, oxcarbazepine, The metabolism of Erdafitinib can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Erdafitinib can be increased when combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Erdafitinib can be decreased when combined with Oxybutynin.]
[L04AB04, adalimumab, The metabolism of Erdafitinib can be increased when combined with Adalimumab.]
[R05DA09, dextromethorphan, The metabolism of Erdafitinib can be decreased when combined with Dextromethorphan.]
[N03AC01, paramethadione, The metabolism of Erdafitinib can be decreased when combined with Paramethadione.]
[H05AA02, teriparatide, The therapeutic efficacy of Teriparatide can be decreased when used in combination with Erdafitinib.]
[N06AB05, paroxetine, The metabolism of Erdafitinib can be decreased when combined with Paroxetine.]
[B01AC04, clopidogrel, The metabolism of Erdafitinib can be decreased when combined with Clopidogrel.]
[N05BA01, diazepam, The metabolism of Erdafitinib can be decreased when combined with Diazepam.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Cinchocaine.]
[S01BC03, diclofenac, The metabolism of Erdafitinib can be decreased when combined with Diclofenac.]
[J01CF01, dicloxacillin, The metabolism of Erdafitinib can be increased when combined with Dicloxacillin.]
[L01EB02, erlotinib, The metabolism of Erdafitinib can be decreased when combined with Erlotinib.]
[L02AA01, diethylstilbestrol, The metabolism of Erdafitinib can be decreased when combined with Diethylstilbestrol.]
[C08CA03, isradipine, The metabolism of Erdafitinib can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The metabolism of Erdafitinib can be increased when combined with Difluocortolone.]
[C01AA04, digitoxin, The serum concentration of Digitoxin can be increased when it is combined with Erdafitinib.]
[C01AA05, digoxin, The serum concentration of Digoxin can be increased when it is combined with Erdafitinib.]
[C04AE04, dihydroergocristine, The metabolism of Erdafitinib can be decreased when combined with Dihydroergocristine.]
[N02CA01, dihydroergotamine, The metabolism of Erdafitinib can be decreased when combined with Dihydroergotamine.]
[N02AA03, hydromorphone, The metabolism of Erdafitinib can be decreased when combined with Hydromorphone.]
[A11CC02, dihydrotachysterol, The risk or severity of adverse effects can be increased when Dihydrotachysterol is combined with Erdafitinib.]
[J05AE08, atazanavir, The metabolism of Erdafitinib can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The metabolism of Erdafitinib can be decreased when combined with Treprostinil.]
[H03BC01, potassium perchlorate, The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Erdafitinib.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Erdafitinib can be decreased when combined with Diltiazem.]
[M02AX03, dimethyl sulfoxide, The metabolism of Erdafitinib can be decreased when combined with Dimethyl sulfoxide.]
[C05CA03, diosmin, The metabolism of Erdafitinib can be decreased when combined with Diosmin.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Diphenhydramine.]
[N05CD10, quazepam, The metabolism of Erdafitinib can be decreased when combined with Quazepam.]
[A03FA02, cisapride, The metabolism of Erdafitinib can be decreased when combined with Cisapride.]
[S01XA23, sirolimus, The serum concentration of Sirolimus can be increased when it is combined with Erdafitinib.]
[S02AA12, rifamycin SV, The metabolism of Erdafitinib can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Erdafitinib can be increased when combined with Rifapentine.]
[D06AX11, rifaximin, The serum concentration of Rifaximin can be increased when it is combined with Erdafitinib.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Ropivacaine.]
[A04AD12, aprepitant, The metabolism of Erdafitinib can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The serum concentration of Tolvaptan can be increased when it is combined with Erdafitinib.]
[L01XG01, bortezomib, The serum concentration of Bortezomib can be increased when it is combined with Erdafitinib.]
[J05AE07, fosamprenavir, The metabolism of Erdafitinib can be decreased when combined with Fosamprenavir.]
[S01BC05, ketorolac, The metabolism of Erdafitinib can be decreased when combined with Ketorolac.]
[C02KX02, ambrisentan, The serum concentration of Ambrisentan can be increased when it is combined with Erdafitinib.]
[C01EB18, ranolazine, The serum concentration of Ranolazine can be increased when it is combined with Erdafitinib.]
[H05BA01, salmon calcitonin, The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Erdafitinib.]
[C01CA04, dopamine, The serum concentration of Dopamine can be increased when it is combined with Erdafitinib.]
[N06AA12, doxepin, The metabolism of Erdafitinib can be decreased when combined with Doxepin.]
[L01DB01, doxorubicin, The serum concentration of Doxorubicin can be increased when it is combined with Erdafitinib.]
[N06AB06, sertraline, The metabolism of Erdafitinib can be decreased when combined with Sertraline.]
[C10AA01, simvastatin, The serum concentration of Simvastatin can be increased when it is combined with Erdafitinib.]
[B05XA02, sodium bicarbonate, The risk or severity of adverse effects can be increased when Sodium bicarbonate is combined with Erdafitinib.]
[C07AB13, talinolol, The serum concentration of Talinolol can be increased when it is combined with Erdafitinib.]
[H01AA01, corticotropin, The metabolism of Erdafitinib can be increased when combined with Corticotropin.]
[M01AC02, tenoxicam, The metabolism of Erdafitinib can be decreased when combined with Tenoxicam.]
[D01BA02, terbinafine, The metabolism of Erdafitinib can be increased when combined with Terbinafine.]
[N03AX11, topiramate, The metabolism of Erdafitinib can be increased when combined with Topiramate.]
[L02BA02, toremifene, The serum concentration of Toremifene can be increased when it is combined with Erdafitinib.]
[C03CA04, torsemide, The metabolism of Erdafitinib can be decreased when combined with Torasemide.]
[G03GA05, follitropin alfa, The therapeutic efficacy of Follitropin can be decreased when used in combination with Erdafitinib.]
[C08CA12, mepirodipine, The metabolism of Erdafitinib can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The metabolism of Erdafitinib can be decreased when combined with Epinephrine.]
[N05CF02, zolpidem, The metabolism of Erdafitinib can be decreased when combined with Zolpidem.]
[N05CF01, zopiclone, The metabolism of Erdafitinib can be decreased when combined with Zopiclone.]
[A11CC01, ergocalciferol, The risk or severity of adverse effects can be increased when Ergocalciferol is combined with Erdafitinib.]
[N02CA02, ergotamine, The metabolism of Erdafitinib can be decreased when combined with Ergotamine.]
[S01AA17, erythromycin, The metabolism of Erdafitinib can be decreased when combined with Erythromycin.]
[G03CA03, estradiol, The metabolism of Erdafitinib can be decreased when combined with Estradiol.]
[J04AK02, ethambutol, The metabolism of Erdafitinib can be decreased when combined with Ethambutol.]
[R03BA09, fluticasone furoate, The metabolism of Erdafitinib can be increased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Erdafitinib can be increased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Erdafitinib can be decreased when combined with Fluvastatin.]
[L02AA03, ethinyl estradiol, The metabolism of Erdafitinib can be decreased when combined with Ethinylestradiol.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Etidocaine.]
[L01CB01, etoposide, The serum concentration of Etoposide can be increased when it is combined with Erdafitinib.]
[L04AD02, tacrolimus, The metabolism of Erdafitinib can be decreased when combined with Tacrolimus.]
[R06AX11, astemizole, The metabolism of Erdafitinib can be decreased when combined with Astemizole.]
[R06AX12, terfenadine, The metabolism of Erdafitinib can be decreased when combined with Terfenadine.]
[N06AX12, bupropion, The metabolism of Erdafitinib can be decreased when combined with Bupropion.]
[N06AB08, fluvoxamine, The metabolism of Erdafitinib can be decreased when combined with Fluvoxamine.]
[C10AA03, pravastatin, The serum concentration of Pravastatin can be increased when it is combined with Erdafitinib.]
[P02CA03, albendazole, The metabolism of Erdafitinib can be decreased when combined with Albendazole.]
[C08CA02, felodipine, The metabolism of Erdafitinib can be decreased when combined with Felodipine.]
[L01BB06, clofarabine, The serum concentration of Clofarabine can be increased when it is combined with Erdafitinib.]
[C01BC04, flecainide, The metabolism of Erdafitinib can be decreased when combined with Flecainide.]
[J01CF05, floxacillin, The metabolism of Erdafitinib can be increased when combined with Flucloxacillin.]
[J02AC01, fluconazole, The metabolism of Erdafitinib can be decreased when combined with Fluconazole.]
[N07CA03, flunarizine, The metabolism of Erdafitinib can be decreased when combined with Flunarizine.]
[N05CD03, flunitrazepam, The metabolism of Erdafitinib can be decreased when combined with Flunitrazepam.]
[D07AC08, fluocinonide, The metabolism of Erdafitinib can be increased when combined with Fluocinonide.]
[H02AB03, fluocortolone, The metabolism of Erdafitinib can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, The metabolism of Erdafitinib can be increased when combined with Ethanol.]
[L01BC09, floxuridine, The metabolism of Erdafitinib can be decreased when combined with Floxuridine.]
[L01BC02, fluorouracil, The metabolism of Erdafitinib can be decreased when combined with Fluorouracil.]
[N06AB03, fluoxetine, The metabolism of Erdafitinib can be decreased when combined with Fluoxetine.]
[S01BC04, flurbiprofen, The metabolism of Erdafitinib can be decreased when combined with Flurbiprofen.]
[J05AE10, darunavir, The serum concentration of Erdafitinib can be increased when it is combined with Darunavir.]
[N03AA04, barbexaclone, The metabolism of Erdafitinib can be increased when combined with Barbexaclone.]
[C10AB04, gemfibrozil, The metabolism of Erdafitinib can be decreased when combined with Gemfibrozil.]
[L01EA02, dasatinib, The serum concentration of Dasatinib can be increased when it is combined with Erdafitinib.]
[N04BC06, cabergoline, The serum concentration of Cabergoline can be increased when it is combined with Erdafitinib.]
[J05AG04, etravirine, The metabolism of Erdafitinib can be increased when combined with Etravirine.]
[L01EH01, lapatinib, The metabolism of Erdafitinib can be decreased when combined with Lapatinib.]
[A10BB01, glyburide, The metabolism of Erdafitinib can be decreased when combined with Glyburide.]
[A10BB09, gliclazide, The metabolism of Erdafitinib can be decreased when combined with Gliclazide.]
[A10BB07, glipizide, The metabolism of Erdafitinib can be decreased when combined with Glipizide.]
[C01BD04, dofetilide, The serum concentration of Dofetilide can be increased when it is combined with Erdafitinib.]
[C02CA04, doxazosin, The metabolism of Erdafitinib can be decreased when combined with Doxazosin.]
[H01AB01, thyrotropin alfa, The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Erdafitinib.]
[L01EX02, sorafenib, The metabolism of Erdafitinib can be decreased when combined with Sorafenib.]
[B01AA12, fluindione, The metabolism of Fluindione can be decreased when combined with Erdafitinib.]
[D01BA01, griseofulvin, The metabolism of Erdafitinib can be increased when combined with Griseofulvin.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Erdafitinib.]
[N01AB01, halothane, The metabolism of Erdafitinib can be decreased when combined with Halothane.]
[C09CA01, losartan, The metabolism of Erdafitinib can be decreased when combined with Losartan.]
[G03DC01, allylestrenol, The metabolism of Erdafitinib can be decreased when combined with Allylestrenol.]
[N05CA16, hexobarbital, The metabolism of Erdafitinib can be decreased when combined with Hexobarbital.]
[J05AG01, nevirapine, The metabolism of Erdafitinib can be decreased when combined with Nevirapine.]
[C08CA10, nilvadipine, The metabolism of Erdafitinib can be decreased when combined with Nilvadipine.]
[C02DB02, hydralazine, The metabolism of Erdafitinib can be decreased when combined with Hydralazine.]
[S02BA01, hydrocortisone, The metabolism of Erdafitinib can be increased when combined with Hydrocortisone.]
[J04AB04, rifabutin, The metabolism of Erdafitinib can be increased when combined with Rifabutin.]
[R02AX02, ibuprofen, The metabolism of Erdafitinib can be decreased when combined with Ibuprofen.]
[L01DB06, idarubicin, The metabolism of Erdafitinib can be decreased when combined with Idarubicin.]
[L01AA06, ifosfamide, The metabolism of Erdafitinib can be increased when combined with Ifosfamide.]
[N06AA02, imipramine, The serum concentration of Imipramine can be increased when it is combined with Erdafitinib.]
[L01CD01, paclitaxel, The metabolism of Erdafitinib can be increased when combined with Paclitaxel.]
[L01CE01, topotecan, The serum concentration of Topotecan can be increased when it is combined with Erdafitinib.]
[S01BC01, indomethacin, The metabolism of Erdafitinib can be decreased when combined with Indomethacin.]
[N06AX17, milnacipran, The metabolism of Erdafitinib can be decreased when combined with Milnacipran.]
[S01XA28, varenicline, The excretion of Varenicline can be decreased when combined with Erdafitinib.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Articaine.]
[A10BH01, sitagliptin, The serum concentration of Sitagliptin can be increased when it is combined with Erdafitinib.]
[N05CH02, ramelteon, The metabolism of Erdafitinib can be decreased when combined with Ramelteon.]
[C10AA06, cerivastatin, The metabolism of Erdafitinib can be increased when combined with Cerivastatin.]
[N06AF05, iproniazid, The metabolism of Erdafitinib can be decreased when combined with Iproniazid.]
[P01AX06, atovaquone, The metabolism of Erdafitinib can be decreased when combined with Atovaquone.]
[J04AC01, isoniazid, The metabolism of Erdafitinib can be decreased when combined with Isoniazid.]
[A02AB01, aluminum hydroxide, The risk or severity of adverse effects can be increased when Aluminum hydroxide is combined with Erdafitinib.]
[L04AC07, tocilizumab, The metabolism of Erdafitinib can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Erdafitinib can be decreased when combined with Ketamine.]
[B01AC22, prasugrel, The metabolism of Erdafitinib can be decreased when combined with Prasugrel.]
[J02AB02, ketoconazole, The metabolism of Erdafitinib can be decreased when combined with Ketoconazole.]
[H02CA04, levoketoconazole, The metabolism of Erdafitinib can be decreased when combined with Levoketoconazole.]
[N05AH03, olanzapine, The metabolism of Erdafitinib can be decreased when combined with Olanzapine.]
[V03AC03, deferasirox, The metabolism of Erdafitinib can be increased when combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Erdafitinib can be increased when combined with Abatacept.]
[N04BB01, amantadine, The serum concentration of Amantadine can be increased when it is combined with Erdafitinib.]
[N03AX18, lacosamide, The metabolism of Erdafitinib can be decreased when combined with Lacosamide.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Lidocaine.]
[N06BA13, armodafinil, The metabolism of Erdafitinib can be increased when combined with Armodafinil.]
[A07DA03, loperamide, The serum concentration of Loperamide can be increased when it is combined with Erdafitinib.]
[C10AA02, lovastatin, The metabolism of Erdafitinib can be decreased when combined with Lovastatin.]
[G03DC03, lynestrenol, The metabolism of Lynestrenol can be decreased when combined with Erdafitinib.]
[L01EG01, temsirolimus, The serum concentration of Temsirolimus can be increased when it is combined with Erdafitinib.]
[G04BX01, magnesium hydroxide, The risk or severity of adverse effects can be increased when Magnesium hydroxide is combined with Erdafitinib.]
[A12CC10, magnesium oxide, The risk or severity of adverse effects can be increased when Magnesium oxide is combined with Erdafitinib.]
[L01EA03, nilotinib, The metabolism of Erdafitinib can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, The serum concentration of Mannitol can be increased when it is combined with Erdafitinib.]
[C01AA08, medigoxin, Erdafitinib may decrease the excretion rate of Metildigoxin which could result in a higher serum level.]
[P01BC02, mefloquine, The serum concentration of Mefloquine can be increased when it is combined with Erdafitinib.]
[N06DX01, memantine, The serum concentration of Memantine can be increased when it is combined with Erdafitinib.]
[N02AB02, meperidine, The metabolism of Erdafitinib can be decreased when combined with Meperidine.]
[N03AB04, mephenytoin, The metabolism of Erdafitinib can be decreased when combined with Mephenytoin.]
[N03AA01, mephobarbital, The metabolism of Erdafitinib can be increased when combined with Methylphenobarbital.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Mepivacaine.]
[L02BG01, aminoglutethimide, The metabolism of Erdafitinib can be increased when combined with Aminoglutethimide.]
[N05AX13, paliperidone, The serum concentration of Paliperidone can be increased when it is combined with Erdafitinib.]
[A10BA02, metformin, The serum concentration of Metformin can be increased when it is combined with Erdafitinib.]
[H01CB03, lanreotide, The metabolism of Erdafitinib can be decreased when combined with Lanreotide.]
[N07BC02, methadone, The metabolism of Erdafitinib can be decreased when combined with Methadone.]
[J05AF05, lamivudine, The serum concentration of Lamivudine can be increased when it is combined with Erdafitinib.]
[H03BB02, methimazole, The metabolism of Erdafitinib can be decreased when combined with Methimazole.]
[N02BG09, methoxyflurane, The metabolism of Erdafitinib can be decreased when combined with Methoxyflurane.]
[V04CG05, methylene blue, The serum concentration of Methylene blue can be increased when it is combined with Erdafitinib.]
[G02AB01, methylergonovine, The metabolism of Erdafitinib can be decreased when combined with Methylergometrine.]
[H02AB04, methylprednisolone, The metabolism of Erdafitinib can be increased when combined with Methylprednisolone.]
[N03AF03, rufinamide, The metabolism of Erdafitinib can be increased when combined with Rufinamide.]
[N02CA04, methysergide, The metabolism of Erdafitinib can be decreased when combined with Methysergide.]
[P01AB01, metronidazole, The metabolism of Erdafitinib can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, The metabolism of Erdafitinib can be increased when combined with Metyrapone.]
[S02AA13, miconazole, The metabolism of Erdafitinib can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Erdafitinib can be decreased when combined with Aminophenazone.]
[N05CD08, midazolam, The metabolism of Erdafitinib can be decreased when combined with Midazolam.]
[G03XB01, mifepristone, The metabolism of Erdafitinib can be increased when combined with Mifepristone.]
[C09CA03, valsartan, The metabolism of Erdafitinib can be decreased when combined with Valsartan.]
[J01FA11, miocamycin, The metabolism of Erdafitinib can be decreased when combined with Miocamycin.]
[L01XX23, mitotane, The metabolism of Erdafitinib can be increased when combined with Mitotane.]
[L03AC01, aldesleukin, The metabolism of Erdafitinib can be decreased when combined with Aldesleukin.]
[C01BD01, amiodarone, The metabolism of Erdafitinib can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Erdafitinib can be decreased when combined with Amitriptyline.]
[N02AA01, morphine, The serum concentration of Morphine can be increased when it is combined with Erdafitinib.]
[L04AB05, certolizumab pegol, The metabolism of Erdafitinib can be increased when combined with Certolizumab pegol.]
[L01EX03, pazopanib, The serum concentration of Pazopanib can be increased when it is combined with Erdafitinib.]
[N05CA02, amobarbital, The metabolism of Erdafitinib can be increased when combined with Amobarbital.]
[P01BA06, amodiaquine, The metabolism of Erdafitinib can be decreased when combined with Amodiaquine.]
[G04CA04, silodosin, The excretion of Silodosin can be decreased when combined with Erdafitinib.]
[G03XC01, raloxifene, The metabolism of Erdafitinib can be decreased when combined with Raloxifene.]
[N03AB05, fosphenytoin, The metabolism of Erdafitinib can be increased when combined with Fosphenytoin.]
[J01CF06, nafcillin, The metabolism of Erdafitinib can be increased when combined with Nafcillin.]
[V03AB15, naloxone, The metabolism of Erdafitinib can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Erdafitinib can be increased when combined with Anakinra.]
[M02AA12, naproxen, The metabolism of Erdafitinib can be decreased when combined with Naproxen.]
[A10BG01, troglitazone, The metabolism of Erdafitinib can be increased when combined with Troglitazone.]
[N06AX21, duloxetine, The metabolism of Erdafitinib can be decreased when combined with Duloxetine.]
[B03XA03, methoxy polyethylene glycol-epoetin beta, The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Erdafitinib.]
[L01CD02, docetaxel, The metabolism of Erdafitinib can be decreased when combined with Docetaxel.]
[N06AX23, desvenlafaxine, The metabolism of Erdafitinib can be decreased when combined with Desvenlafaxine.]
[H05BX02, paricalcitol, The risk or severity of adverse effects can be increased when Paricalcitol is combined with Erdafitinib.]
[C10AD02, niacin, The metabolism of Erdafitinib can be decreased when combined with Niacin.]
[C08CA04, nicardipine, The metabolism of Erdafitinib can be decreased when combined with Nicardipine.]
[P02DA01, niclosamide, The metabolism of Erdafitinib can be decreased when combined with Niclosamide.]
[N04BC05, pramipexole, The serum concentration of Pramipexole can be increased when it is combined with Erdafitinib.]
[C01CA03, norepinephrine, The serum concentration of Norepinephrine can be increased when it is combined with Erdafitinib.]
[G03DC02, norethindrone, The metabolism of Erdafitinib can be decreased when combined with Norethisterone.]
[C02KX01, bosentan, The metabolism of Erdafitinib can be increased when combined with Bosentan.]
[N06AA10, nortriptyline, The serum concentration of Nortriptyline can be increased when it is combined with Erdafitinib.]
[R05DA07, noscapine, The metabolism of Erdafitinib can be decreased when combined with Noscapine.]
[H01CB02, octreotide, The serum concentration of Erdafitinib can be increased when it is combined with Octreotide.]
[J01FA05, oleandomycin, The metabolism of Erdafitinib can be decreased when combined with Oleandomycin.]
[L04AC04, rilonacept, The metabolism of Erdafitinib can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Erdafitinib can be increased when combined with Omeprazole.]
[A14AA08, oxandrolone, The metabolism of Erdafitinib can be decreased when combined with Oxandrolone.]
[H02AB05, paramethasone, The metabolism of Erdafitinib can be increased when combined with Paramethasone.]
[N05CA01, pentobarbital, The metabolism of Erdafitinib can be increased when combined with Pentobarbital.]
[N02BE03, phenacetin, The metabolism of Erdafitinib can be decreased when combined with Phenacetin.]
[N03AA02, phenobarbital, The metabolism of Erdafitinib can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, The metabolism of Erdafitinib can be decreased when combined with Phenprocoumon.]
[M02AA01, phenylbutazone, The metabolism of Erdafitinib can be increased when combined with Phenylbutazone.]
[N03AB02, phenytoin, The metabolism of Erdafitinib can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Erdafitinib can be increased when combined with Golimumab.]
[L02BB03, bicalutamide, The metabolism of Erdafitinib can be decreased when combined with Bicalutamide.]
[C08CX01, mibefradil, The serum concentration of Mibefradil can be increased when it is combined with Erdafitinib.]
[N05AG02, pimozide, The metabolism of Erdafitinib can be decreased when combined with Pimozide.]
[J05AE01, saquinavir, The metabolism of Erdafitinib can be decreased when combined with Saquinavir.]
[S01BC06, piroxicam, The metabolism of Erdafitinib can be decreased when combined with Piroxicam.]
[J05AG02, delavirdine, The metabolism of Erdafitinib can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Erdafitinib can be decreased when combined with Irbesartan.]
[A10BG02, rosiglitazone, The metabolism of Erdafitinib can be decreased when combined with Rosiglitazone.]
[A03AE01, alosetron, The metabolism of Erdafitinib can be decreased when combined with Alosetron.]
[L04AC08, canakinumab, The metabolism of Erdafitinib can be increased when combined with Canakinumab.]
[J05AE03, ritonavir, The metabolism of Erdafitinib can be decreased when combined with Ritonavir.]
[V03AB21, potassium iodide, The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Erdafitinib.]
[C10AA08, pitavastatin, The metabolism of Erdafitinib can be decreased when combined with Pitavastatin.]
[C02CA01, prazosin, The serum concentration of Prazosin can be increased when it is combined with Erdafitinib.]
[S03BA02, prednisolone, The metabolism of Erdafitinib can be increased when combined with Prednisolone.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Erdafitinib can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Erdafitinib can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Erdafitinib can be increased when combined with Probenecid.]
[C01BA02, procainamide, The serum concentration of Procainamide can be increased when it is combined with Erdafitinib.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Erdafitinib is combined with Procaine.]
[C10AB05, fenofibrate, The metabolism of Erdafitinib can be decreased when combined with Fenofibrate.]
[G03DA04, progesterone, The metabolism of Erdafitinib can be decreased when combined with Progesterone.]
[N05AA03, promazine, The metabolism of Erdafitinib can be decreased when combined with Promazine.]
[R06AD02, promethazine, The metabolism of Erdafitinib can be decreased when combined with Promethazine.]
[R06AX26, fexofenadine, The serum concentration of Fexofenadine can be increased when it is combined with Erdafitinib.]
[L01XH02, romidepsin, The serum concentration of Romidepsin can be increased when it is combined with Erdafitinib.]
[N01AX10, propofol, The metabolism of Erdafitinib can be decreased when combined with Propofol.]
[N02AC04, propoxyphene, The metabolism of Erdafitinib can be decreased when combined with Dextropropoxyphene.]
[H03BA02, propylthiouracil, The therapeutic efficacy of Propylthiouracil can be decreased when used in combination with Erdafitinib.]
[R03DC03, montelukast, The metabolism of Erdafitinib can be decreased when combined with Montelukast.]
[N07XX07, dalfampridine, The serum concentration of Dalfampridine can be increased when it is combined with Erdafitinib.]
[C01BA01, quinidine, The serum concentration of Quinidine can be increased when it is combined with Erdafitinib.]
[P01BC01, quinine, The serum concentration of Quinine can be increased when it is combined with Erdafitinib.]
[A02BA02, ranitidine, The serum concentration of Ranitidine can be increased when it is combined with Erdafitinib.]
[C02AA02, reserpine, The serum concentration of Reserpine can be increased when it is combined with Erdafitinib.]
[J04AB02, rifampin, The metabolism of Erdafitinib can be increased when combined with Rifampicin.]
[J01FA06, roxithromycin, The metabolism of Erdafitinib can be decreased when combined with Roxithromycin.]
[S01BC08, salicylic acid, The metabolism of Erdafitinib can be decreased when combined with Salicylic acid.]
[N05CA06, secobarbital, The metabolism of Erdafitinib can be increased when combined with Secobarbital.]
[N04BD01, selegiline, The metabolism of Erdafitinib can be decreased when combined with Selegiline.]
[H01CB01, somatostatin, The metabolism of Erdafitinib can be decreased when combined with Somatostatin.]
[L01CD04, cabazitaxel, The serum concentration of Cabazitaxel can be increased when it is combined with Erdafitinib.]
[L01FD03, ado-trastuzumab emtansine, The serum concentration of Trastuzumab emtansine can be increased when it is combined with Erdafitinib.]
[N02BA03, choline salicylate, The serum concentration of Choline salicylate can be increased when it is combined with Erdafitinib.]
[V09GA01, technetium Tc 99m sestamibi, The serum concentration of Technetium Tc-99m sestamibi can be increased when it is combined with Erdafitinib.]
[N03AG01, valproic acid, The metabolism of Erdafitinib can be decreased when combined with Valproic acid.]
[D07AB02, hydrocortisone butyrate, The metabolism of Erdafitinib can be increased when combined with Hydrocortisone butyrate.]
